Bayer Annual Report 2016

Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world In fiscal 18, the Group employed around 117,000 people and had sales of 396 billion euros.

Bayer annual report 2016. View bayerannualreport17pdf from COM AR17 at College of Advanced Scientific Technique, Sahiwal Annual Report 17 Augmented Version Bayer Annual Report 17 The integrated Bayer Annual Report. Bayer Annual Report 16 Key Data by Segment Pharmaceuticals Consumer Health Crop Science Animal Health € million Net sales (external) Change1 Currencyadjusted change1 Intersegment sales Net sales (total) Other operating income EBIT1 EBIT before special items1 EBITDA before special items1 ROCE1 Net cash provided by operating activities. Excel files (XLS) ;.

Since 18 the Annual Report is available only as an online version The online version contains the notes to the consolidated financial statements of the Bayer Group, along with additional information. Bayer Annual Report Augmented Version 16, p 56ff (Sustainability Management) Any relevant policies, procedures, and activities that the company plans to undertake by its next COP to fulfill this criterion, including goals, timelines, metrics, and responsible staff Criterion 2 The COP describes value chain implementation. Annual Report 19 (bilingual) Report of the DirectorGeneral – July 1987 to June 19 (bilingual) Report of the DirectorGeneral – July 1986 to June 1987 (bilingual).

Exhibit 991 Transcript Bayer AG Meet Management 16 Tuesday, th September 16 Bayer AG Meet Management 16 Tuesday, th September 16 Introduction Dr J?rgen Beunink Head of Investor Relations, Bayer Good morning everybody and welcome to our 18th Meet Management Conference. BASF Report 16 (PDF) ;. Bayer Annual Report 16 € million Change1 Currencyadjusted change1 Other operating income EBIT1 – Assets Capital expenditures Depreciation, amortization and impairments Liabilities Research and development expenses 15 figures restated 1 For definition see Combined Management Report, Chapter “Alternative Performance Measures Used by.

16 Annual Report and Accounts Consolidated financial statements Income statement (IFRS) EUR million 1 Jan – 31 Dec 16 1 Jan – 31 Dec 15 Change in % Net interest income Risk provisions in the credit business Net interest income after risk provisions 1,475 – 87 1,3 1,612 – 264 1,348. Bayer CEO Werner Baumann (right) and CFO Johannes Dietsch present the new Annual Report Sales of the Bayer Group increased in 16 by 15 percent (Fx & portfolio adj 35 percent) to EUR 46,769 million (15 EUR 46,085 million). Positive earnings contributions resulted from price increases, the lower cost of goods sold as well as the Cydectin™ business that Bayer acquired These more than offset a decline in volumes and slightly higher expenses for research and development EBIT climbed by 151% to € 107 million, with no special items (Q2 16 € 0 million) recorded.

32nd Annual JP Morgan Healthcare Conference, San Francisco Presentation by Andreas Fibig, Head of Bayer HealthCare Pharmaceuticals Download PDF collect (2 MB) January 13, 14 Commerzbank German Investment Seminar 14, New York Investor Handout Download PDF collect (1 MB). Number of employees in fulltime equivalents (FTE). Consumer Health brings consumers some of the world’s bestknown and most trusted overthecounter (OTC) medications, nutritional supplements and other selfcare products.

Subsidiary and affiliated companies of the Bayer Group as of December 31, 16, pursuant to Section 313 of the German Commercial Code Bayer Annual Report 16 6 Bayer Annual Report 16 Fully Consolidated Subsidiaries Company name Place of business Bayer’s interest (%) Bayer Essure Inc Milpitas, USA 100. About CRISPR Therapeutics AG 1500 Employees Based in Cambridge, Massachusetts CRISPR Therapeutics has established strategic partnerships with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its whollyowned US. Innovation plays an important role in overcoming global challenges and is a key driver of future growth at Bayer Overview;.

Bayer Annual Report 17 Information on Research and Development in 17 R&D expenses R&D expenses before special items Share of R&D expenses R&D employees € million % % of sales FTE Pharmaceuticals Consumer Health Crop Science Animal Health Reconciliation Total 16 figures restated Back to index Research and Development Expenses Full Year 17. Fx adj = currencyadjusted;. ANNUAL REPORT 16 A New Era Begins CONTENTS 1 Page 4 BMW Group in Figures Page 8 Report of the Supervisory Board Page 16 Statement of the Chairman of the Board of Management 2 COMBINED MANAGEMENT REPORT Page 22 General Information on the BMW Group Page 22 Organisational Structure and Business Model.

June 8, 16 dbAccess German, Swiss & Austrian Conference, Berlin, Germany Presentation by Werner Baumann, CEO of Bayer AG Download PDF collect (8 MB) June 7, 16 Goldman Sachs 37th Annual Global Healthcare Conference, Rancho Palos Verdes, USA Investor Handout Download PDF collect (5 MB) May 4, 16 Deutsche Bank 41st Annual Health Care. Bayer CropScience Limited 3 Annual Report 1617 may be mutually agreed upon between the Company and Bayer AG and as given under the statement setting out the material facts annexed to this Notice, for Item No 7 RESOLVED FURTHER THAT WKH %RDUG RI 'LUHFWRUV RI WKH &RPSDQ\ LQFOXGLQJ LWV &RPPLWWHH WKHUHRI EH DQG LV KHUHE\ DXWKRULHG WR. Bayer's commitment to employees and society in fiscal 17 16 figures restated;.

Another record year for Bayer Watch Bayer CEO Werner Baumann’s statement on the fiscal year 16For more information on this topic, visit wwwannualreport. A global excessofloss policy has also existed for the Crop Science segment since January 16 In this global credit insurance program, more than 80% of this segment’s receivables are insured up to a maximum total annual compensation payment of € 300 million (16 € 300 million). St Louis, October 27, Today, the US Environmental Protection Agency (EPA) announced a new 5year registration for XtendiMax® herbicide with VaporGrip® Technology, an important weedcontrol tool for many US growers The EPA stated that "With today's decision, farmers now have the certainty they need to make plans for their 21 growing season.

Fiscal year 16 compared with fiscal year 15 Revenue decreased $ billion or 9%, primarily due to the impact of the net revenue deferral from Windows 10 of $66 billion and an unfavorable foreign currency impact of approximately $38 billion or 4%. Bayer CropScience Limited Annual Report 1516 ROUTE MAP TO THE VENUE OF THE 58TH ANNUAL GENERAL MEETING OF BAYER CROPSCIENCE LIMITED Day & Date Monday, September 12, 16 Time 1100 AM Venue Yashwantrao Chavan Pratishthan Auditorium, Y B Chavan. Title Bayer Annual Report 16 Subject AR_16 Last modified by Judith Nestmann Created Date 2/21/17 PM Company Bayer Other titles five_year_summary.

Bayer Australia Limited Australian Packaging Covenant 19 Annual Report Page 2 10 Company Information Bayer is a global enterprise with core competencies in the fields of health care, nutrition and agriculture ayers mission statement, ayer Science for a etter Life is core to the production of. Annual Report 16 Color AcresZones Zone 1 16 Zone 2 69 Zone 3 12 Show true color Fiscal 16 Another record year for Bayer – good progress with the acquisition of Monsanto Group sales €468 billion (Fx & portfolio adj 35%) Substantial sales and earnings increases at Pharmaceuticals. The reimbursement claims of € 85 million (16 € 1 million) predominantly consisted of receivables from insurance companies in connection with product liability claims In 16, miscellaneous receivables included a € 441 million receivable from Dow AgroSciences LLC, United States, for damages and royalty payments resulting from the infringement of Bayer’s rights to the LibertyLink.

Bayer CEO Werner Baumann (right) and CFO Johannes Dietsch present the new Annual Report Sales of the Bayer Group increased in 16 by 15 percent (Fx & portfolio adj 35 percent) to EUR 46,769 million (15 EUR 46,085 million). Bayer Annual Report 16 Bayer Group Consolidated Statements of Financial Position Note Dec 31, 15 Dec 31, 16 € million Noncurrent assets Goodwill 17 Other intangible assets Property, plant and equipment 18 Investments accounted for using the equity method 19 Other financial assets Other receivables 23 Deferred taxes 14. The integrated Annual Report combines our financial reporting and our nonfinancial statement, which contains all material sustainability information required by commercial law Our aim is to elucidate the interactions between financial, ecological and societal factors and underline their influence on our company’s longterm success.

Excel files (XLS) ;. 2 Annual Report 16 could not continue in the same way Eventually the idea of having energy stakeholders around the world engage in broad discussions took hold In this, OPEC played a leadership role As it has done many times before, during similarly challenging times, OPEC began to intensify its long. Products Products Annual Report 16 17 Download (PDF, English, 9,5 MB) Annual Report 15 16 Download (PDF, English, 23 MB) Annual Report 14 15.

Title Bayer Annual Report 16 Subject AR_16 Author Nina Klarzynski Last modified by Nina Klarzynski Created Date 2/21/17 PM Company. Annual Reports 61st BCSL – Annual Report for Financial Year 1819 Download (PDF, English, 526 MB) The digital magazine offers interesting glimpses of Bayer’s global scope as a lifescience company Magazine;. BASF Report 16 (PDF) ;.

Baer Annual Report 16 Annual Report Augmented Version 16 Color Zones Acres Zone 1 16 Zone 2 69 Zone 3 12 Show true color Fiscal 16 Another record year for Bayer – good progress with the acquisition of Monsanto Group sales €468 billion (Fx & portfolio adj 35%). Annual Report 16 including consolidated financial statements, Combined Management Report of Bayer AG, Report of the Supervisory Board Voting Results 5919 % of the statutory capital of Bayer AG was present at the Annual Stockholders’ Meeting 17. Products Products Annual Report 16 17 Download (PDF, English, 9,5 MB) Annual Report 15 16 Download (PDF, English, 23 MB) Annual Report 14 15.

Bayer Annual Report 16 Key Data by Segment Pharmaceuticals Consumer Health Crop Science Animal Health € million Net sales (external) Change1 Currencyadjusted change1 Intersegment sales Net sales (total) Other operating income EBIT1 EBIT before special items1 EBITDA before special items1 ROCE1 Net cash provided by operating activities. Our key growth products once again delivered strong performance, with their combined sales rising by 0 percent (Fx adj) to €1,445 million (Q1 16 €1,187 million) Find out more Consumer Health Sales of Consumer Health rose by 26 percent (Fx & portfolio adj) in the first quarter of 17 to €1,601 million. Another record year for Bayer Watch Bayer CEO Werner Baumann’s statement on the fiscal year 16For more information on this topic, visit wwwannualreport.

Bayer Annual Report 16. ANNUAL REPORT 16 A New Era Begins CONTENTS 1 Page 4 BMW Group in Figures Page 8 Report of the Supervisory Board Page 16 Statement of the Chairman of the Board of Management 2 COMBINED MANAGEMENT REPORT Page 22 General Information on the BMW Group Page 22 Organisational Structure and Business Model. Bayer Annual Report 16.

Bayer Annual Report 16 Bayer Group Consolidated Statements of Financial Position Note Dec 31, 15 Dec 31, 16 € million Noncurrent assets Goodwill 17 Other intangible assets Property, plant and equipment 18 Investments accounted for using the equity method 19 Other financial assets Other receivables 23 Deferred taxes 14. Leverkusen, August , 19 USbased company Elanco Animal Health has entered into a definitive agreement to acquire Bayer's Animal Health business, Bayer announced on Tuesday The transaction is valued at 76 billion US dollars consisting of 53 billion US dollars in cash, subject to customary purchase price adjustments, and 23 billion US dollars in Elanco stock based on the. Bayer CropScience Limited 3 Annual Report 1617 may be mutually agreed upon between the Company and Bayer AG and as given under the statement setting out the material facts annexed to this Notice, for Item No 7 RESOLVED FURTHER THAT the Board of Directors of the Company (including its Committee thereof) be and is hereby authorized to.

Management Report How have Bayer’s sales and earnings evolved in the Second Quarter of 17?. The answers are provided by the Management Report as at June 30, 17 Integrated Annual Report 16 View report AR Integrated Annual Report 15 View report AR Integrated Annual Report 14 View report Investor Services. For definition see Annual Report 16, Chapter “Alternative Performance Measures Used by the Bayer Group” 2 Marketing rights owned by an affiliate of Johnson & Johnson, USA 3 Marketing rights owned by Regeneron Pharmaceuticals Inc, USA.

Title Bayer Annual Report 16 Subject AR_16 Author Nina Klarzynski Last modified by Nina Klarzynski Created Date 2/21/17 PM Company. Deferred income included an upfront payment, originally amounting to US$ 1 billion, in connection with the strategic pharmaceutical collaboration agreed between Bayer and Merck & Co, Inc, United States, in the field of soluble guanylate cyclase (sGC) modulationThis deferred income is being amortized over a period of 135 years as the obligations are satisfied. About CRISPR Therapeutics AG 1500 Employees Based in Cambridge, Massachusetts CRISPR Therapeutics has established strategic partnerships with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its whollyowned US.

Bayer CropScience Limited Annual Report 1516 ROUTE MAP TO THE VENUE OF THE 58TH ANNUAL GENERAL MEETING OF BAYER CROPSCIENCE LIMITED Day & Date Monday, September 12, 16 Time 1100 AM Venue Yashwantrao Chavan Pratishthan Auditorium, Y B Chavan. Bayer CropScience Limited 3 Annual Report 1617 may be mutually agreed upon between the Company and Bayer AG and as given under the statement setting out the material facts annexed to this Notice, for Item No 7 RESOLVED FURTHER THAT the Board of Directors of the Company (including its Committee thereof) be and is hereby authorized to. Get a detailed Sensex annual report of Bayer CropScience on stock/share exchange market for the financial 16 and more at Moneycontrolcom.

Download the entire BASF Report 16 as a PDF Download PDF (61 MB) Download all tables. Bayer Annual Report 16. $509, as compared to last year’s asreported fullyear EPS of $299, adding that EPS is expected to grow in the first quarter of fiscal 18Reflecting the value its innovation brings, the company delivered exceptionally on its operational plan, while continuing to progress on the closing of the merger with Bayer as it looks forward to the opportunity to create even greater benefits for.

It also shows that economic growth declined certainly in Europe and Germany but the economy of China continued to grow and progress (Mokhtar et al 16) Comprehensiveness Bayer Germany has shown in its annual report that global growth in the economy went on to decrease in the year 19 compared to that. Innovation plays an important role in overcoming global challenges and is a key driver of future growth at Bayer Overview;. June 8, 16 dbAccess German, Swiss & Austrian Conference, Berlin, Germany Presentation by Werner Baumann, CEO of Bayer AG Download PDF collect (8 MB) June 7, 16 Goldman Sachs 37th Annual Global Healthcare Conference, Rancho Palos Verdes, USA Investor Handout Download PDF collect (5 MB) May 4, 16 Deutsche Bank 41st Annual Health Care.

Fx & p adj = currency and portfolioadjusted;. Download the entire BASF Report 16 as a PDF Download PDF (61 MB) Download all tables. As of 18, the Bayer Annual Report is only available digitally As it contains supplementary information such as notes to the consolidated financial statements of Bayer Group, it is considered an “Augmented Version” The Annual Report combines our financial reporting and our nonfinancial statement, which contains all material.

Investor Annual Report 16 58th Annual Report (April 15 to March 16) Download PDF (337 MB).